Sylogist Ltd. (TSE:SYZ - Free Report) - Investment analysts at Cormark reduced their FY2025 EPS estimates for shares of Sylogist in a note issued to investors on Friday, March 14th. Cormark analyst G. Fairweather now expects that the company will post earnings of $0.09 per share for the year, down from their previous estimate of $0.14. The consensus estimate for Sylogist's current full-year earnings is $0.24 per share. Cormark also issued estimates for Sylogist's FY2026 earnings at $0.17 EPS and FY2027 earnings at $0.36 EPS.
Sylogist Stock Down 2.4 %
Shares of Sylogist stock traded down C$0.20 on Monday, hitting C$8.31. 11,091 shares of the company traded hands, compared to its average volume of 60,825. The company has a 50-day moving average price of C$9.49 and a 200 day moving average price of C$10.09. The company has a quick ratio of 0.51, a current ratio of 0.54 and a debt-to-equity ratio of 47.19. Sylogist has a 12-month low of C$8.09 and a 12-month high of C$11.60. The company has a market cap of C$196.49 million, a PE ratio of 184.42 and a beta of 0.82.
Sylogist Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 12th. Stockholders of record on Wednesday, March 12th were given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date of this dividend was Friday, February 28th. Sylogist's dividend payout ratio is currently 88.77%.
Sylogist Company Profile
(
Get Free Report)
Sylogist Ltd., a software company, provides mission-critical software-as-a-service solutions in Canada, the United States, and the United Kingdom. The company offers SylogistMission constituent relationship management system, which includes donor management, fundraising, volunteer management, and program delivery; and enterprise resource management, such as accounting and financial management, grant and award management, budget management, payroll and human resources, analytics and reporting, and support and training.
Read More
Before you consider Sylogist, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sylogist wasn't on the list.
While Sylogist currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
